$INFI: Infinity Reports Clinical and Translational Data from Expansion …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 /PRNewswire/ — Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) announced that data to be presented today at the 33 Annual Meeting of the Society for …

Full article address: https://www.benzinga.com/pressreleases/18/11/r12675502/infinity-reports-clinical-and-translational-data-from-expansion-cohort

Related News:

$INFI: Infinity Pharmaceuticals provides business update

$INFI: Infinity Pharmaceuticals’ (INFI) CEO Adelene Perkins on Q3 2018 …

$BMY $INFI: Infinity Pharma teams up with Bristol-Myers Squibb in urothelial cancer

$BMY $INFI: Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New …

$INFI: Infinity Pharma up 7% premarket on $22M milestone from Verastem

Latest News:

$XPO: XPO Logistics Launches New Website Experience

$LMT: Lockheed Martin, Diehl and Saab Unveil Collaboration to Counter …

$SF: Knight Signs GUD (Bueno) Latin American Strategic Funding Deal …

$NE: Noble Corp.: Good Fleet, But High Debt Load Limits Flexibility

$WIT: Wipro Launches QuMiC to Accelerate Migration to Oracle Cloud

$WMT $EBAY: Walmart Reports Earnings: Analysts’ Expectations

$WCG: Passport lawsuit claims state Medicaid cuts could push it to insolvency

$FB $TWTR: Why Is Facebook Up, Twitter Down This Earnings Season?

$XOM: Here’s Why The Best Is Yet to Come for ExxonMobil

$DBX: HomeSign Acquisition Will Help Dropbox Expand Business Segment

$CRUS $AAPL: Does Cirrus Logic Have a Future Beyond Apple?